A new American Heart Association initiative is working to increase screening for lipoprotein(a) (Lp[a]) at community health ...

Cancer vaccine experts are worried that if the Trump administration takes a hostile posture towards mRNA broadly, cancer ...

Yet, within the past 24 hours, Trump has doubled the tariffs on India to 50%, imposed an additional 15% on Japan, announced a ...

Q2 2025 Earnings Call Transcript August 6, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.83836, ...

The leading ER+/ HER2 -ve Breast Cancer Companies such as AstraZeneca, Atossa Therapeutics, Inc., Accutar Biotechnology Inc, ...

If a deal is confirmed and consummated, Novartis would claim ownership of a biotech that has raised something of a stir in ...

Meanwhile, mRNA vaccine maker Moderna is cutting around 500 jobs (10% of its workforce) as part of a commitment to save $1.5 ...

The omnipresence of medical misinformation has fundamentally changed how certain portions of the general public approach their health and make care decisions.

--Novartis made a takeover approach for Avidity Biosciences, a biotechnology company that specializes in rare diseases with a market value of $5.8 billion, the Financial Times reports, citing unnamed ...

MS Pharma & Kashiv Biosciences enter licensing and supply pact for commercialization of ADL-018/bOmalizumab in the MENA region: Jordan Thursday, August 7, 2025, 11:00 Hrs [IST] MS ...

Switzerland is now paying one of Donald Trump’s highest tariffs after the government failed in its last-ditch effort to get ...

Glencore maintains its UK listing; Britain seeks clarity on China's embassy plans; Novartis considers acquiring biotech firm ...